BBVA
BIO icon

Banco Bilbao Vizcaya Argentaria’s Bio-Rad Laboratories Class A BIO Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-699
Closed -$242K – 734
2024
Q1 		$242K Buy
699
+14
+2% +$4.6K ﹤0.01% 737
2023
Q4 		$221K Buy
685
+25
+4% +$7.84K ﹤0.01% 714
2023
Q3 		$237K Sell
660
-4
-0.6% -$1.54K ﹤0.01% 701
2023
Q2 		$252K Buy
664
+8
+1% +$3.26K ﹤0.01% 682
2023
Q1 		$314K Buy
656
+118
+22% +$55.2K ﹤0.01% 670
2022
Q4 		$226K Buy
538
+27
+5% +$10.9K ﹤0.01% 686
2022
Q3 		$213K Sell
511
-13
-2% -$6.48K ﹤0.01% 699
2022
Q2 		$259K Buy
524
+5
+1% +$2.6K ﹤0.01% 653
2022
Q1 		$298K Sell
519
-22
-4% -$13.3K ﹤0.01% 667
2021
Q4 		$410K Buy
541
+13
+2% +$9.73K 0.01% 696
2021
Q3 		$394K Buy
528
+10
+2% +$7.49K 0.01% 659
2021
Q2 		$334K Buy
518
+40
+8% +$24.3K 0.01% 687
2021
Q1 		$273K Buy
478
+8
+2% +$4.74K 0.01% 696
2020
Q4 		$273K Buy
470
+64
+16% +$36.4K 0.01% 654
2020
Q3 		$209K Buy
+406
New +$206K 0.01% 656

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's BIO Position: Q2 2024 in Review

Banco Bilbao Vizcaya Argentaria sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2024, closing a stake of 699 shares — an estimated $242K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in BIO in Q3 2020 and held it in 15 quarters. The position peaked at $410K in Q4 2021. 440 funds tracked by Wall St. Rank hold BIO as of Q2 2024.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Bio-Rad Laboratories Class A position as of Q2 2024 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 699 Bio-Rad Laboratories Class A shares in Q2 2024, an estimated $242K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Bio-Rad Laboratories Class A in Q3 2020 and held it in 15 quarters.
  • Banco Bilbao Vizcaya Argentaria's Bio-Rad Laboratories Class A position peaked at $410K in Q4 2021.
  • 440 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2024.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q2 2024, filed 6 Aug 2024.